Difference between revisions of "EYE5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
(Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo...")
 
 
(6 intermediate revisions by the same user not shown)
Line 6: Line 6:
  
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
−
 
+
__TOC__
 
<br />
 
<br />
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
Line 18: Line 18:
 
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
−
|- |Usual ductal hyperplasia||Disease||
+
|-
−
|Usual Ductal Hyperplasia
+
|
 +
==== CHAPTER 2 (TUMOURS OF THE CONJUCTIVA AND CARUNCLE) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[EYE5:Epithelial_conjunctival_inclusion_cyst|Epithelial conjunctival inclusion cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Reactive_epithelial_hyperplasia_of_the_conjunctiva|Reactive epithelial hyperplasia of the conjunctiva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Papillary_and_follicular_conjunctivitis|Papillary and follicular conjunctivitis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Pterygium_and_pingueculum|Pterygium and pingueculum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Epibulbar_choristoma_(dermoid;_dermolipoma;_complex_choristoma)|Epibulbar choristoma (dermoid; dermolipoma; complex choristoma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Epibulbar_osseous_choristoma|Epibulbar osseous choristoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Conjunctival_squamous_cell_papilloma|Conjunctival squamous cell papilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Conjunctival_oncocytoma|Conjunctival oncocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Hereditary_benign_intraepithelial_dyskeratosis|Hereditary benign intraepithelial dyskeratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Conjunctival_squamous_intraepithelial_neoplasia|Conjunctival squamous intraepithelial neoplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Conjunctival_squamous_cell_carcinoma|Conjunctival squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Adenosquamous_carcinoma|Adenosquamous carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Benign_epithelial_melanosis_of_the_conjunctiva|Benign epithelial melanosis of the conjunctiva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Junctional,_compound_and_subepithelial_conjunctival_naevi|Junctional, compound and subepithelial conjunctival naevi]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Inflamed_juvenile_conjunctival_naevus|Inflamed juvenile conjunctival naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Blue_naevus_of_the_conjunctiva|Blue naevus of the conjunctiva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:WNT-activated_deep_penetrating/plexiform_melanocytoma_(naevus)|WNT-activated deep penetrating/plexiform melanocytoma (naevus)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Combined_naevus|Combined naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Conjunctival_melanocytic_intraepithelial_lesions|Conjunctival melanocytic intraepithelial lesions]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Conjunctival_melanoma|Conjunctival melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 3 (TUMOURS OF THE EYELID) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[EYE5:Epidermal_inclusion_cyst|Epidermal inclusion cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Intratarsal_cyst_|Intratarsal cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Phakomatous_choristoma|Phakomatous choristoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Molluscum_contagiosum|Molluscum contagiosum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Verruca_vulgaris|Verruca vulgaris]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Squamous_cell_papilloma|Squamous cell papilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Seborrheic_keratosis|Seborrheic keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Inverted_follicular_keratosis|Inverted follicular keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Actinic_keratosis|Actinic keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Basal_cell_carcinoma|Basal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Squamous_cell_carcinoma|Squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Merkel_cell_carcinoma|Merkel cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Ductal_hidrocystoma|Ductal hidrocystoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Sebaceous_hyperplasia,_adenoma,_and_sebaceoma|Sebaceous hyperplasia, adenoma, and sebaceoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Syringoma|Syringoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Mixed_tumour|Mixed tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Tubular_adenoma|Tubular adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Syringocystadenoma_papilliferum|Syringocystadenoma papilliferum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Pilomatricoma|Pilomatricoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Trichilemmoma|Trichilemmoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Sebaceous_carcinoma|Sebaceous carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Signet-ring_cell/histiocytoid_carcinoma|Signet-ring cell/histiocytoid carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Mucinous_carcinoma|Mucinous carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Endocrine_mucin-producing_sweat_gland_carcinoma|Endocrine mucin-producing sweat gland carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Microcystic_adnexal_carcinoma|Microcystic adnexal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Apocrine_carcinoma|Apocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Naevi_of_the_eyelid|Naevi of the eyelid]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Spitz_naevus|Spitz naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:In-situ_cutaneous_melanoma|In-situ cutaneous melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Invasive_cutaneous_melanoma|Invasive cutaneous melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 4 (TUMOURS OF THE UVEAL TRACT) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[EYE5:Ectopic_tissue|Ectopic tissue]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Implantation_cyst|Implantation cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Pigmented_epithelial_cyst|Pigmented epithelial cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Lisch_nodule|Lisch nodule]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Ocular_melanocytosis|Ocular melanocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Iris_naevus|Iris naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Iris_melanoma|Iris melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Choroidal_and_ciliary_body_naevi|Choroidal and ciliary body naevi]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Uveal_melanocytoma|Uveal melanocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Bilateral_diffuse_uveal_melanocytic_proliferation|Bilateral diffuse uveal melanocytic proliferation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Choroidal_and_ciliary_body_melanomas|Choroidal and ciliary body melanomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 5 (TUMOURS OF THE RETINA AND NEUROEPITHELIUM) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[EYE5:Astrocytic_tumours|Astrocytic tumours]]
 
|Disease
 
|Disease
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 796:
 
|
 
|
 
|-
 
|-
−
|Columnar Cell Lesions, Including Flat Epithelial Atypia||Disease||
+
|[[EYE5:Nodular_and_massive_retinal_gliosis|Nodular and massive retinal gliosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 807:
 
|
 
|
 
|-
 
|-
−
|Atypical Ductal Hyperplasia||Disease||
+
|[[EYE5:Retinocytoma|Retinocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 818:
 
|
 
|
 
|-
 
|-
−
|Sclerosing Adenosis||Disease||
+
|[[EYE5:Retinoblastoma|Retinoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 829:
 
|
 
|
 
|-
 
|-
−
|Apocrine Adenosis and Adenoma||Disease||
+
|[[EYE5:Hamartoma_of_the_retinal_pigment_epithelium|Hamartoma of the retinal pigment epithelium]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 840:
 
|
 
|
 
|-
 
|-
−
|Microglandular Adenosis||Disease||
+
|[[EYE5:Congenital_hypertrophy_of_the_retinal_pigment_epithelium|Congenital hypertrophy of the retinal pigment epithelium]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 851:
 
|
 
|
 
|-
 
|-
−
|Radial Scar/Complex Sclerosing Lesion||Disease||
+
|[[EYE5:Reactive_hyperplasia_of_the_retinal_pigment_epithelium|Reactive hyperplasia of the retinal pigment epithelium]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 862:
 
|
 
|
 
|-
 
|-
−
|Tubular Adenoma||Disease||
+
|[[EYE5:Adenoma_and_adenocarcinoma_of_the_retinal_pigment_epithelium|Adenoma and adenocarcinoma of the retinal pigment epithelium]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 90: Line 873:
 
|
 
|
 
|-
 
|-
−
|Lactating Adenoma||Disease||
+
|[[EYE5:Reactive_epithelial_hyperplasia_of_the_ciliary_epithelium|Reactive epithelial hyperplasia of the ciliary epithelium]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 884:
 
|
 
|
 
|-
 
|-
−
|Ductal Adenoma||Disease||
+
|[[EYE5:Nodular_hyperplasia_of_the_ciliary_epithelium|Nodular hyperplasia of the ciliary epithelium]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 895:
 
|
 
|
 
|-
 
|-
−
|Pleomorphic Adenoma||Disease||
+
|[[EYE5:Glioneuronal_hamartoma_of_the_ciliary_body|Glioneuronal hamartoma of the ciliary body]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 906:
 
|
 
|
 
|-
 
|-
−
|Adenomyoepithelioma||Disease||
+
|[[EYE5:Adenoma_and_adenocarcinoma_of_the_ciliary_body|Adenoma and adenocarcinoma of the ciliary body]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 917:
 
|
 
|
 
|-
 
|-
−
|Malignant Adenomyoepithelioma||Disease||
+
|[[EYE5:Medulloepithelioma_of_the_ciliary_body|Medulloepithelioma of the ciliary body]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 928:
 
|
 
|
 
|-
 
|-
−
|Intraductal Papilloma||Disease||
 
 
|
 
|
 +
==== CHAPTER 6 (TUMOURS OF THE OPTIC DISC AND OPTIC NERVE) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Papillary Ductal Carcinoma In Situ||Disease||
+
|[[EYE5:Optic_nerve_choristoma|Optic nerve choristoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 960:
 
|
 
|
 
|-
 
|-
−
|Encapsulated Papillary Carcinoma||Disease||
+
|[[EYE5:Gliomas_of_the_optic_nerve|Gliomas of the optic nerve]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 971:
 
|
 
|
 
|-
 
|-
−
|Solid Papillary Carcinoma (In Situ and Invasive)||Disease||
+
|[[EYE5:Medulloepithelioma_of_the_optic_disc_and_optic_nerve|Medulloepithelioma of the optic disc and optic nerve]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 171: Line 982:
 
|
 
|
 
|-
 
|-
−
|Invasive Papillary Carcinoma||Disease||
+
|[[EYE5:Meningioma_of_the_optic_nerve|Meningioma of the optic nerve]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Melanocytoma_of_the_optic_disc_and_optic_nerve|Melanocytoma of the optic disc and optic nerve]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 7 (TUMOURS OF THE LACRIMAL GLAND) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[EYE5:Dacryops_cyst|Dacryops cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Pleomorphic_adenoma_of_the_lacrimal_gland|Pleomorphic adenoma of the lacrimal gland]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Lacrimal_gland_oncocytoma|Lacrimal gland oncocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Myoepithelioma|Myoepithelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Intraductal_carcinoma|Intraductal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Carcinoma_ex_pleomorphic_adenoma|Carcinoma ex pleomorphic adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Primary_ductal_adenocarcinoma_of_the_lacrimal_gland|Primary ductal adenocarcinoma of the lacrimal gland]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Secretory_carcinoma|Secretory carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 1,135:
 
|
 
|
 
|-
 
|-
−
|Atypical Lobular Hyperplasia||Disease||
+
|[[EYE5:Epithelial-myoepithelial_carcinoma|Epithelial-myoepithelial carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 1,146:
 
|
 
|
 
|-
 
|-
−
|Lobular Carcinoma In Situ||Disease||
+
|[[EYE5:Acinic_cell_carcinoma|Acinic cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 198: Line 1,157:
 
|
 
|
 
|-
 
|-
−
|Ductal Carcinoma In Situ||Disease||
+
|[[EYE5:Adenocarcinoma,_NOS|Adenocarcinoma, NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 1,168:
 
|
 
|
 
|-
 
|-
−
|Invasive Breast Carcinoma of No Special Type||Disease||
 
 
|
 
|
 +
==== CHAPTER 8 (TUMOURS OF THE LACRIMAL DRAINAGE SYSTEM) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Microinvasive Carcinoma||Disease||
+
|[[EYE5:Papillomas_(squamous_and_inverted)|Papillomas (squamous and inverted)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 1,200:
 
|
 
|
 
|-
 
|-
−
|Invasive lobular Carcinoma||Disease||
+
|[[EYE5:Squamous_cell_carcinoma|Squamous cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 1,211:
 
|
 
|
 
|-
 
|-
−
|Tubular Carcinoma||Disease||
+
|[[EYE5:Lymphoepithelial_carcinoma|Lymphoepithelial carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 1,222:
 
|
 
|
 
|-
 
|-
−
|Cribriform Carcinoma||Disease||
+
|[[EYE5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 1,233:
 
|
 
|
 
|-
 
|-
−
|Mucinous Carcinoma||Disease||
+
|[[EYE5:Other_salivary_gland-type_carcinomas_of_the_lacrimal_drainage_system|Other salivary gland-type carcinomas of the lacrimal drainage system]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 1,244:
 
|
 
|
 
|-
 
|-
−
|Mucinous Cystadenocarcinoma||Disease||
+
|[[EYE5:Adenocarcinoma_NOS_of_the_lacrimal_drainage_system|Adenocarcinoma NOS of the lacrimal drainage system]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 1,255:
 
|
 
|
 
|-
 
|-
−
|Invasive Micropapillary Carcinoma||Disease||
+
|[[EYE5:Melanoma_involving_the_lacrimal_drainage_system|Melanoma involving the lacrimal drainage system]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 1,266:
 
|
 
|
 
|-
 
|-
−
|Carcinoma with Apocrine Differentiation||Disease||
 
 
|
 
|
 +
==== CHAPTER 9 (TUMOURS OF THE ORBIT) ====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Metaplastic Carcinoma||Disease||
+
|[[EYE5:Orbital_dermoid_cysts_and_other_orbital_cysts|Orbital dermoid cysts and other orbital cysts]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 1,298:
 
|
 
|
 
|-
 
|-
−
|Acinic Cell Carcinoma||Disease||
+
|[[EYE5:Cavernous_vascular_malformation|Cavernous vascular malformation]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 1,309:
 
|
 
|
 
|-
 
|-
−
|Adenoid Cystic Carcinoma||Disease||Katherine Geiersbach / Jun Liao
+
|[[EYE5:Combined_lymphatic-venous_malformation_of_the_orbit|Combined lymphatic-venous malformation of the orbit]]
−
|10/12/02022
+
|Disease
−
|11/11/2023
+
|
−
|COMPLETE
+
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
−
|Hui Chen / Katherine Geiersbach
 
−
|12/6/2023
 
−
|2021 template added
 
 
|-
 
|-
−
|Secretory Carcinoma||Disease||Hui Chen / Morteza Seifi
+
|[[EYE5:Orbital_venous_malformation_|Orbital venous malformation]]
−
|10/12/2022
+
|Disease
−
|11/11/2023
+
|
−
|PENDING
+
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
−
|Katherine Geiersbach
 
 
|
 
|
−
|2021 template added
 
 
|-
 
|-
−
|Mucoepidermoid Carcinoma||Disease||
+
|[[EYE5:Arteriovenous_malformation|Arteriovenous malformation]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 1,342:
 
|
 
|
 
|-
 
|-
−
|Polymorphous Adenocarcinoma||Disease||
+
|[[EYE5:Orbital_glial_heterotopia|Orbital glial heterotopia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 1,353:
 
|
 
|
 
|-
 
|-
−
|Tall Cell Carcinoma with Reversed Polarity||Disease||H. Evin Gulbahce
+
|[[EYE5:Mesenchymal_hamartoma_of_the_orbit|Mesenchymal hamartoma of the orbit]]
−
|8/11/2023
+
|Disease
−
|10/11/2023
+
|
−
|COMPLETE
+
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
−
|Katherine Geiersbach
 
 
|
 
|
−
|2021 template added
 
 
|-
 
|-
−
|Neuroendocrine Tumour||Disease||
+
|[[EYE5:Teratoma|Teratoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 1,375:
 
|
 
|
 
|-
 
|-
−
|Neuroendocrine Carcinoma||Disease||
+
|[[EYE5:Yolk_sac_tumour|Yolk sac tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 1,386:
 
|
 
|
 
|-
 
|-
−
|Hamartoma||Disease||
+
|[[EYE5:Primary_orbital_melanoma|Primary orbital melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 1,397:
 
|
 
|
 
|-
 
|-
−
|Fibroadenoma||Disease||H. Evin Gulbahce / Patricija Zot
 
−
|8/11/2023
 
−
|11/11/2023
 
−
|PENDING
 
 
|
 
|
 +
==== CHAPTER 10 (HAEMATOLYMPHOID TUMOURS) ====
 
|
 
|
 +
----
 
|
 
|
−
|2021 template added
+
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Phyllodes Tumour||Disease||H. Evin Gulbahce / Patricija Zot / Emilie Lalonde / Katherine Geiersbach
+
|[[EYE5:Reactive_lymphoid_hyperplasia|Reactive lymphoid hyperplasia]]
−
|8/11/2023
+
|Disease
−
|11/11/2023
+
|
−
|PENDING
+
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
 
|
 
|
−
|2021 template added
 
 
|-
 
|-
−
|Syringomatous Tumour||Disease||
+
|[[EYE5:IgG4-related_disease|IgG4-related disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 405: Line 1,440:
 
|
 
|
 
|-
 
|-
−
|Nipple Adenoma||Disease||
+
|[[EYE5:Primary_choroidal_lymphoma|Primary choroidal lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 1,451:
 
|
 
|
 
|-
 
|-
−
|Paget disease of the Breast||Disease||
+
|[[EYE5:Primary_vitreoretinal_large_B-cell_lymphoma|Primary vitreoretinal large B-cell lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 1,462:
 
|
 
|
 
|-
 
|-
−
|Haemangioma||Disease||
+
|[[EYE5:Extranodal_marginal_zone_lymphoma_|Extranodal marginal zone lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 1,473:
 
|
 
|
 
|-
 
|-
−
|Angiomatosis||Disease||
+
|[[EYE5:Follicular_lymphoma|Follicular lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 1,484:
 
|
 
|
 
|-
 
|-
−
|Atypical Vascular Lesions||Disease||
+
|[[EYE5:Mantle_cell_lymphoma|Mantle cell lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 1,495:
 
|
 
|
 
|-
 
|-
−
|Postradiation Angiosarcoma of the Breast||Disease||
+
|[[EYE5:Chronic_lymphocytic_leukaemia/small_lymphocytic_lymphoma|Chronic lymphocytic leukaemia/small lymphocytic lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 459: Line 1,506:
 
|
 
|
 
|-
 
|-
−
|Primary Angiosarcoma of the Breast||Disease||
+
|[[EYE5:Diffuse_large_B-cell_lymphoma_|Diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 468: Line 1,517:
 
|
 
|
 
|-
 
|-
−
|Nodular Fasciitis||Disease||
+
|[[EYE5:Plasmacytoma|Plasmacytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 1,528:
 
|
 
|
 
|-
 
|-
−
|Myofibroblastoma||Disease||
+
|[[EYE5:CD30_positive_lymphoproliferative_disorders|CD30 positive lymphoproliferative disorders]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 1,539:
 
|
 
|
 
|-
 
|-
−
|Desmoid Fibromatosis||Disease||
+
|[[EYE5:T-cell_lymphomas|T-cell lymphomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 1,550:
 
|
 
|
 
|-
 
|-
−
|Inflammatory Myofibroblastic Tumour||Disease||Yajuan Liu
+
|[[EYE5:Extranodal_lymphoma_of_mature_NK_or_T-cell_lineage|Extranodal lymphoma of mature NK or T-cell lineage]]
−
|8/11/2023
+
|Disease
−
|11/11/2023
+
|
−
|COMPLETE
+
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
−
|Katherine Geiersbach
 
−
|12/6/2023
 
−
|2021 template added
 
 
|-
 
|-
−
|Schwannoma||Disease||
+
|[[EYE5:Extramedullary_myeloid_sarcoma|Extramedullary myeloid sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 513: Line 1,572:
 
|
 
|
 
|-
 
|-
−
|Neurofibroma||Disease||
+
|[[EYE5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 1,583:
 
|
 
|
 
|-
 
|-
−
|Granular Cell Tumour||Disease||
+
|[[EYE5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 1,594:
 
|
 
|
 
|-
 
|-
−
|Leiomyoma||Disease||
+
|[[EYE5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 1,605:
 
|
 
|
 
|-
 
|-
−
|Leiomyosarcoma||Disease||
+
|[[EYE5:Langerhans_cell_tumours|Langerhans cell tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 1,616:
 
|
 
|
 
|-
 
|-
−
|Lipoma||Disease||
+
|[[EYE5:Xanthelasma|Xanthelasma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 558: Line 1,627:
 
|
 
|
 
|-
 
|-
−
|Angiolipoma||Disease||
+
|[[EYE5:Adult_orbital_xanthogranulomatous_disease|Adult orbital xanthogranulomatous disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 1,638:
 
|
 
|
 
|-
 
|-
−
|Liposarcoma||Disease||
 
 
|
 
|
 +
==== CHAPTER 11 (SOFT TISSUE AND BONE TUMOURS) ====
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Pseudoangiomatous Stromal Hyperplasia||Disease||
+
|[[EYE5:Conjunctival_stromal_tumour_and_ocular_surface_fibroma|Conjunctival stromal tumour and ocular surface fibroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 1,670:
 
|
 
|
 
|-
 
|-
−
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||
+
|[[EYE5:Fibrous_histiocytoma|Fibrous histiocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 1,681:
 
|
 
|
 
|-
 
|-
−
|Follicular Lymphoma||Disease||
+
|[[EYE5:Nodular_and_proliferative_fasciitis,_proliferative_myositis|Nodular and proliferative fasciitis, proliferative myositis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 1,692:
 
|
 
|
 
|-
 
|-
−
|Diffuse Large B-cell Lymphoma||Disease||
+
|[[EYE5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 1,703:
 
|
 
|
 
|-
 
|-
−
|Burkitt Lymphoma||Disease||
+
|[[EYE5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 621: Line 1,714:
 
|
 
|
 
|-
 
|-
−
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||
+
|[[EYE5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 1,725:
 
|
 
|
 
|-
 
|-
−
|Gynaecomastia||Disease||
+
|[[EYE5:Angiomyxoma|Angiomyxoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 639: Line 1,736:
 
|
 
|
 
|-
 
|-
−
|Carcinoma In Situ||Disease||
+
|[[EYE5:Benign_lipomatous_tumours|Benign lipomatous tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 648: Line 1,747:
 
|
 
|
 
|-
 
|-
−
|Invasive Carcinoma||Disease||
+
|[[EYE5:Malignant_adipocytic_tumours|Malignant adipocytic tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 1,758:
 
|
 
|
 
|-
 
|-
−
|Metastases to the Breast||Disease||
+
|[[EYE5:Rhabdomyosarcoma_family|Rhabdomyosarcoma family]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 1,769:
 
|
 
|
 
|-
 
|-
−
|BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||Constance Albarracin / Katherine Geiersbach
+
|[[EYE5:Leiomyoma|Leiomyoma]]
−
|12/6/2023
+
|Disease
−
|3/6/2024
+
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 1,780:
 
|
 
|
 
|-
 
|-
−
|Cowden Syndrome||Disease||
+
|[[EYE5:Mesectodermal_leiomyoma|Mesectodermal leiomyoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 1,791:
 
|
 
|
 
|-
 
|-
−
|Ataxia-Telangiectasia||Disease||Evin Gulbahce / Katherine Geiersbach
+
|[[EYE5:Leiomyosarcoma|Leiomyosarcoma]]
−
|12/11/2023
+
|Disease
−
|3/11/2024
+
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
−
|Katherine Geiersbach
 
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Li-Fraumeni Syndrome, TP53-Associated||Disease||
+
|[[EYE5:Schwannoma|Schwannoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 1,813:
 
|
 
|
 
|-
 
|-
−
|Li-Fraumeni Syndrome, CHEK2-Associated||Disease||
+
|[[EYE5:Neurofibroma|Neurofibroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 1,824:
 
|
 
|
 
|-
 
|-
−
|CDH1-Associated Breast Cancer||Disease||
+
|[[EYE5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 1,835:
 
|
 
|
 
|-
 
|-
−
|PALB2-Associated Cancers||Disease||Constance Albarracin / Katherine Geiersbach
+
|[[EYE5:Granular_cell_tumour|Granular cell tumour]]
−
|12/8/2023
+
|Disease
−
|3/8/2024
+
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 1,846:
 
|
 
|
 
|-
 
|-
−
|Peutz-Jeghers Syndrome||Disease||
+
|[[EYE5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 1,857:
 
|
 
|
 
|-
 
|-
−
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
+
|[[EYE5:Masson_tumour|Masson tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Infantile_haemangioma|Infantile haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Lobular_capillary_haemangioma|Lobular capillary haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Lymphangiectasia|Lymphangiectasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Haemangioblastoma|Haemangioblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Glomus_tumour|Glomus tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:PEComa|PEComa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Epithelioid_sarcoma|Epithelioid sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Synovial_sarcoma|Synovial sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Osteoma|Osteoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Osteoblastoma|Osteoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Osteosarcoma|Osteosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Soft_tissue_chondroma|Soft tissue chondroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Fibrous_dysplasia|Fibrous dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Haemangioma_of_bone|Haemangioma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Giant_cell_tumour_of_bone|Giant cell tumour of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Ewing_sarcoma|Ewing sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 12 (METASTASES TO THE EYE AND SURROUNDING STRUCTURES) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[EYE5:Metastases_to_ocular_adnexal_structures|Metastases to ocular adnexal structures]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Metastases_to_intra-ocular_structures|Metastases to intra-ocular structures]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 13 (GENETIC TUMOUR SYNDROMES) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[EYE5:Retinoblastoma_syndrome|Retinoblastoma syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Von_Hippel_Lindau_syndrome|Von Hippel Lindau syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[EYE5:Sturge_Weber_syndrome|Sturge Weber syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[EYE5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[EYE5:Goldenhar_syndrome|Goldenhar syndrome]]
 +
|Disease
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 745: Line 2,261:
 
|
 
|
 
|
 
|
−
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
 
|-
 
|-
−
|Polygenic Component of Breast Cancer Susceptibility
+
|[[EYE5:Muir-Torre_syndrome|Muir-Torre syndrome]]
 
|Disease
 
|Disease
 
|
 
|

Latest revision as of 13:54, 10 September 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.


WHO Classification of Eye and Orbit Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (TUMOURS OF THE CONJUCTIVA AND CARUNCLE)
Epithelial conjunctival inclusion cyst Disease
Reactive epithelial hyperplasia of the conjunctiva Disease
Papillary and follicular conjunctivitis Disease
Pterygium and pingueculum Disease
Epibulbar choristoma (dermoid; dermolipoma; complex choristoma) Disease
Epibulbar osseous choristoma Disease
Conjunctival squamous cell papilloma Disease
Conjunctival oncocytoma Disease
Hereditary benign intraepithelial dyskeratosis Disease
Conjunctival squamous intraepithelial neoplasia Disease
Conjunctival squamous cell carcinoma Disease
Adenosquamous carcinoma Disease
Benign epithelial melanosis of the conjunctiva Disease
Junctional, compound and subepithelial conjunctival naevi Disease
Inflamed juvenile conjunctival naevus Disease
Blue naevus of the conjunctiva Disease
WNT-activated deep penetrating/plexiform melanocytoma (naevus) Disease
Combined naevus Disease
Conjunctival melanocytic intraepithelial lesions Disease
Conjunctival melanoma Disease

CHAPTER 3 (TUMOURS OF THE EYELID)
Epidermal inclusion cyst Disease
Intratarsal cyst Disease
Phakomatous choristoma Disease
Molluscum contagiosum Disease
Verruca vulgaris Disease
Squamous cell papilloma Disease
Seborrheic keratosis Disease
Inverted follicular keratosis Disease
Actinic keratosis Disease
Basal cell carcinoma Disease
Squamous cell carcinoma Disease
Merkel cell carcinoma Disease
Ductal hidrocystoma Disease
Sebaceous hyperplasia, adenoma, and sebaceoma Disease
Syringoma Disease
Mixed tumour Disease
Tubular adenoma Disease
Syringocystadenoma papilliferum Disease
Pilomatricoma Disease
Trichilemmoma Disease
Sebaceous carcinoma Disease
Adenoid cystic carcinoma Disease
Signet-ring cell/histiocytoid carcinoma Disease
Mucinous carcinoma Disease
Endocrine mucin-producing sweat gland carcinoma Disease
Microcystic adnexal carcinoma Disease
Apocrine carcinoma Disease
Naevi of the eyelid Disease
Spitz naevus Disease
In-situ cutaneous melanoma Disease
Invasive cutaneous melanoma Disease

CHAPTER 4 (TUMOURS OF THE UVEAL TRACT)
Ectopic tissue Disease
Implantation cyst Disease
Pigmented epithelial cyst Disease
Lisch nodule Disease
Ocular melanocytosis Disease
Iris naevus Disease
Iris melanoma Disease
Choroidal and ciliary body naevi Disease
Uveal melanocytoma Disease
Bilateral diffuse uveal melanocytic proliferation Disease
Choroidal and ciliary body melanomas Disease

CHAPTER 5 (TUMOURS OF THE RETINA AND NEUROEPITHELIUM)
Astrocytic tumours Disease
Nodular and massive retinal gliosis Disease
Retinocytoma Disease
Retinoblastoma Disease
Hamartoma of the retinal pigment epithelium Disease
Congenital hypertrophy of the retinal pigment epithelium Disease
Reactive hyperplasia of the retinal pigment epithelium Disease
Adenoma and adenocarcinoma of the retinal pigment epithelium Disease
Reactive epithelial hyperplasia of the ciliary epithelium Disease
Nodular hyperplasia of the ciliary epithelium Disease
Glioneuronal hamartoma of the ciliary body Disease
Adenoma and adenocarcinoma of the ciliary body Disease
Medulloepithelioma of the ciliary body Disease

CHAPTER 6 (TUMOURS OF THE OPTIC DISC AND OPTIC NERVE)
Optic nerve choristoma Disease
Gliomas of the optic nerve Disease
Medulloepithelioma of the optic disc and optic nerve Disease
Meningioma of the optic nerve Disease
Melanocytoma of the optic disc and optic nerve Disease

CHAPTER 7 (TUMOURS OF THE LACRIMAL GLAND)
Dacryops cyst Disease
Pleomorphic adenoma of the lacrimal gland Disease
Lacrimal gland oncocytoma Disease
Myoepithelioma Disease
Intraductal carcinoma Disease
Carcinoma ex pleomorphic adenoma Disease
Adenoid cystic carcinoma Disease
Primary ductal adenocarcinoma of the lacrimal gland Disease
Secretory carcinoma Disease
Mucoepidermoid carcinoma Disease
Epithelial-myoepithelial carcinoma Disease
Acinic cell carcinoma Disease
Adenocarcinoma, NOS Disease

CHAPTER 8 (TUMOURS OF THE LACRIMAL DRAINAGE SYSTEM)
Papillomas (squamous and inverted) Disease
Squamous cell carcinoma Disease
Lymphoepithelial carcinoma Disease
Mucoepidermoid carcinoma Disease
Other salivary gland-type carcinomas of the lacrimal drainage system Disease
Adenocarcinoma NOS of the lacrimal drainage system Disease
Melanoma involving the lacrimal drainage system Disease

CHAPTER 9 (TUMOURS OF THE ORBIT)
Orbital dermoid cysts and other orbital cysts Disease
Cavernous vascular malformation Disease
Combined lymphatic-venous malformation of the orbit Disease
Orbital venous malformation Disease
Arteriovenous malformation Disease
Orbital glial heterotopia Disease
Mesenchymal hamartoma of the orbit Disease
Teratoma Disease
Yolk sac tumour Disease
Primary orbital melanoma Disease

CHAPTER 10 (HAEMATOLYMPHOID TUMOURS)
Reactive lymphoid hyperplasia Disease
IgG4-related disease Disease
Primary choroidal lymphoma Disease
Primary vitreoretinal large B-cell lymphoma Disease
Extranodal marginal zone lymphoma Disease
Follicular lymphoma Disease
Mantle cell lymphoma Disease
Chronic lymphocytic leukaemia/small lymphocytic lymphoma Disease
Diffuse large B-cell lymphoma Disease
Plasmacytoma Disease
CD30 positive lymphoproliferative disorders Disease
T-cell lymphomas Disease
Extranodal lymphoma of mature NK or T-cell lineage Disease
Extramedullary myeloid sarcoma Disease
Juvenile xanthogranuloma Disease
Rosai-Dorfman disease Disease
Erdheim-Chester disease Disease
Langerhans cell tumours Disease
Xanthelasma Disease
Adult orbital xanthogranulomatous disease Disease

CHAPTER 11 (SOFT TISSUE AND BONE TUMOURS)
Conjunctival stromal tumour and ocular surface fibroma Disease
Fibrous histiocytoma Disease
Nodular and proliferative fasciitis, proliferative myositis Disease
Solitary fibrous tumour Disease
Inflammatory myofibroblastic tumour Disease
Dermatofibrosarcoma protuberans Disease
Angiomyxoma Disease
Benign lipomatous tumours Disease
Malignant adipocytic tumours Disease
Rhabdomyosarcoma family Disease
Leiomyoma Disease
Mesectodermal leiomyoma Disease
Leiomyosarcoma Disease
Schwannoma Disease
Neurofibroma Disease
Solitary circumscribed neuroma Disease
Granular cell tumour Disease
Malignant peripheral nerve sheath tumour Disease
Masson tumour Disease
Infantile haemangioma Disease
Lobular capillary haemangioma Disease
Lymphangiectasia Disease
Epithelioid haemangioma Disease
Haemangioblastoma Disease
Angiosarcoma Disease
Glomus tumour Disease
Myopericytoma, including myofibroma Disease
PEComa Disease
Epithelioid sarcoma Disease
Synovial sarcoma Disease
Alveolar soft part sarcoma Disease
Osteoma Disease
Osteoblastoma Disease
Osteosarcoma Disease
Soft tissue chondroma Disease
Mesenchymal chondrosarcoma Disease
Fibrous dysplasia Disease
Haemangioma of bone Disease
Epithelioid haemangioendothelioma Disease
Angiosarcoma of bone Disease
Aneurysmal bone cyst Disease
Giant cell tumour of bone Disease
Ewing sarcoma Disease

CHAPTER 12 (METASTASES TO THE EYE AND SURROUNDING STRUCTURES)
Metastases to ocular adnexal structures Disease
Metastases to intra-ocular structures Disease

CHAPTER 13 (GENETIC TUMOUR SYNDROMES)
Retinoblastoma syndrome Disease
BAP1 tumour predisposition syndrome Disease
Von Hippel Lindau syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Sturge Weber syndrome Disease
Neurofibromatosis type 1 (NF1) Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Goldenhar syndrome Disease
Muir-Torre syndrome Disease


Retrieved from "https://ccga.io/index.php?title=EYE5:Volunteer_Assignments_and_Opportunities&oldid=15413"